Tomoko Nukui

1.5k total citations
17 papers, 349 citations indexed

About

Tomoko Nukui is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Tomoko Nukui has authored 17 papers receiving a total of 349 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 6 papers in Pulmonary and Respiratory Medicine and 6 papers in Oncology. Recurrent topics in Tomoko Nukui's work include DNA Repair Mechanisms (3 papers), BRCA gene mutations in cancer (3 papers) and Glutathione Transferases and Polymorphisms (2 papers). Tomoko Nukui is often cited by papers focused on DNA Repair Mechanisms (3 papers), BRCA gene mutations in cancer (3 papers) and Glutathione Transferases and Polymorphisms (2 papers). Tomoko Nukui collaborates with scholars based in United States and Canada. Tomoko Nukui's co-authors include Marjorie Romkes, Jill M. Siegfried, Joel L. Weissfeld, Richard Day, Brenda Diergaarde, Roberta B. Ness, Shama Buch, Arjun Pennathur, Yan Lin and Guoying Yu and has published in prestigious journals such as Journal of Clinical Oncology, American Journal of Respiratory and Critical Care Medicine and Cancer.

In The Last Decade

Tomoko Nukui

17 papers receiving 341 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Tomoko Nukui United States 10 163 110 95 71 61 17 349
Jiang Shen China 9 357 2.2× 179 1.6× 53 0.6× 86 1.2× 31 0.5× 16 506
Geriolda Topi Sweden 9 110 0.7× 99 0.9× 42 0.4× 61 0.9× 27 0.4× 14 320
Suzan Lambin Belgium 11 55 0.3× 115 1.0× 81 0.9× 86 1.2× 63 1.0× 14 285
Tereza Hálková Czechia 10 91 0.6× 96 0.9× 42 0.4× 114 1.6× 41 0.7× 22 355
Louise M. Rasmussen Denmark 8 155 1.0× 150 1.4× 50 0.5× 54 0.8× 61 1.0× 8 487
Danthasinghe Waduge Badrajee Piyarathna United States 11 190 1.2× 41 0.4× 59 0.6× 114 1.6× 39 0.6× 14 324
Bogdan Michalski Poland 10 82 0.5× 134 1.2× 43 0.5× 43 0.6× 29 0.5× 20 339
Linda A. Villani Canada 9 218 1.3× 70 0.6× 33 0.3× 80 1.1× 60 1.0× 16 388
Bangbei Wan China 9 153 0.9× 49 0.4× 107 1.1× 85 1.2× 11 0.2× 33 319
Yiding Bian China 12 135 0.8× 32 0.3× 52 0.5× 69 1.0× 49 0.8× 19 322

Countries citing papers authored by Tomoko Nukui

Since Specialization
Citations

This map shows the geographic impact of Tomoko Nukui's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tomoko Nukui with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tomoko Nukui more than expected).

Fields of papers citing papers by Tomoko Nukui

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tomoko Nukui. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tomoko Nukui. The network helps show where Tomoko Nukui may publish in the future.

Co-authorship network of co-authors of Tomoko Nukui

This figure shows the co-authorship network connecting the top 25 collaborators of Tomoko Nukui. A scholar is included among the top collaborators of Tomoko Nukui based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tomoko Nukui. Tomoko Nukui is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Abécassis, Irina, Andrew J. Sedgewick, Marjorie Romkes, et al.. (2019). PARP1 rs1805407 Increases Sensitivity to PARP1 Inhibitors in Cancer Cells Suggesting an Improved Therapeutic Strategy. Scientific Reports. 9(1). 3309–3309. 22 indexed citations
2.
Weissfeld, Joel L., Yan Lin, Brenda F. Kurland, et al.. (2015). Lung Cancer Risk Prediction Using Common SNPs Located in GWAS-Identified Susceptibility Regions. Journal of Thoracic Oncology. 10(11). 1538–1545. 32 indexed citations
3.
Villaruz, Liza C., Grace Huang, Marjorie Romkes, et al.. (2015). MicroRNA expression profiling predicts clinical outcome of carboplatin/paclitaxel-based therapy in metastatic melanoma treated on the ECOG-ACRIN trial E2603. Clinical Epigenetics. 7(1). 58–58. 18 indexed citations
4.
Siegfried, Jill M., Yan Lin, Brenda Diergaarde, et al.. (2015). Expression of PAM50 Genes in Lung Cancer: Evidence that Interactions between Hormone Receptors and HER2/HER3 Contribute to Poor Outcome. Neoplasia. 17(11). 817–825. 25 indexed citations
5.
Yu, Guoying, Jose D. Herazo‐Maya, Tomoko Nukui, et al.. (2014). Matrix Metalloproteinase-19 Promotes Metastatic Behavior In Vitro and is Associated with Increased Mortality in Non–Small Cell Lung Cancer. American Journal of Respiratory and Critical Care Medicine. 190(7). 780–790. 52 indexed citations
6.
Weissfeld, Joel L., Brenda Diergaarde, Tomoko Nukui, et al.. (2014). Inherited Variation in the ATP-Binding Cassette Transporter ABCB1 and Survival after Chemotherapy for Stage III–IV Lung Cancer. Journal of Thoracic Oncology. 9(9). 1264–1271. 7 indexed citations
7.
Siegfried, Jill M., Yan Lin, Laura P. Stabile, et al.. (2014). Prediction of NSCLC Survival With the PAM50 Breast Cancer Signature. International Journal of Radiation Oncology*Biology*Physics. 90(5). S71–S72. 1 indexed citations
8.
Song, Ji Young, Jill M. Siegfried, Brenda Diergaarde, et al.. (2013). Genetic variation in ESR2 and estrogen receptor-beta expression in lung tumors. Cancer Epidemiology. 37(4). 518–522. 7 indexed citations
9.
Hamilton, Ronald L., Michal T. Krauze, Marjorie Romkes, et al.. (2013). Pathologic and gene expression features of metastatic melanomas to the brain. Cancer. 119(15). 2737–2746. 32 indexed citations
10.
Styn, Mindi A., Tomoko Nukui, Marjorie Romkes, et al.. (2013). CYP2A6 Genotype and Smoking Behavior in Current Smokers Screened for Lung Cancer. Substance Use & Misuse. 48(7). 490–494. 8 indexed citations
11.
Bogen, Debra L., J M Perel, Joseph C. Helsel, et al.. (2012). Pharmacologic evidence to support clinical decision making for peripartum methadone treatment. Psychopharmacology. 225(2). 441–451. 31 indexed citations
12.
Romkes, Marjorie, Malgorzata Harasymczuk, Tomoko Nukui, et al.. (2012). Association of high T-cell immune infiltrate and low hemorrhage in melanoma brain metastases (MBMs) with prolonged survival.. Journal of Clinical Oncology. 30(15_suppl). 8528–8528. 2 indexed citations
13.
Zhong, Shilong, Tomoko Nukui, Shama Buch, et al.. (2011). Effects of ERCC2 Lys751Gln (A35931C) and CCND1 (G870A) Polymorphism on Outcome of Advanced-Stage Squamous Cell Carcinoma of the Head and Neck Are Treatment Dependent. Cancer Epidemiology Biomarkers & Prevention. 20(11). 2429–2437. 8 indexed citations
14.
Buch, Shama, Brenda Diergaarde, Tomoko Nukui, et al.. (2011). Genetic variability in DNA repair and cell cycle control pathway genes and risk of smoking‐related lung cancer. Molecular Carcinogenesis. 51(S1). E11–20. 28 indexed citations
15.
Styn, Mindi A., Tomoko Nukui, Marjorie Romkes, et al.. (2008). The impact of genetic variation in DRD2 and SLC6A3 on smoking cessation in a cohort of participants 1 year after enrollment in a lung cancer screening study. American Journal of Medical Genetics Part B Neuropsychiatric Genetics. 150B(2). 254–261. 17 indexed citations
16.
Nukui, Tomoko, Richard Day, Heather Gordish‐Dressman, et al.. (2006). The absence of interaction between drug metabolizing enzyme genotypes and maternal lifestyle factors on glycophorin A somatic mutation frequency levels in newborns. Pharmacogenetics and Genomics. 16(2). 129–138. 3 indexed citations
17.
Nukui, Tomoko, et al.. (2004). Maternal/newborn GSTT1 null genotype contributes to risk of preterm, low birthweight infants. Pharmacogenetics. 14(9). 569–576. 56 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jiang Shen Breakdown of academic impact, for papers by Geriolda Topi Breakdown of academic impact, for papers by Suzan Lambin Breakdown of academic impact, for papers by Tereza Hálková Breakdown of academic impact, for papers by Louise M. Rasmussen Breakdown of academic impact, for papers by Danthasinghe Waduge Badrajee Piyarathna Breakdown of academic impact, for papers by Bogdan Michalski Breakdown of academic impact, for papers by Linda A. Villani Breakdown of academic impact, for papers by Bangbei Wan Breakdown of academic impact, for papers by Yiding Bian
Rankless by CCL
2026